Skip to main content
ALLIANCE PHARMA PLC logo

ALLIANCE PHARMA PLC — Investor Relations & Filings

Ticker · APH ISIN · GB0031030819 LEI · 213800RYIWZA4Q5WPZ13 IL Wholesale and retail trade
Open in API
Filings indexed 492 across all filing types
Latest filing 2021-06-10 Regulatory Filings
Country GB United Kingdom
Listing IL APH

About ALLIANCE PHARMA PLC

https://www.alliancepharmaceuticals.com/

Alliance Pharma PLC is an international specialty pharmaceutical company with a primary focus on consumer healthcare. The company's business model is centered on the acquisition, licensing, and marketing of a portfolio of consumer health products and prescription medicines. It operates globally, investing in its key brands to empower consumers to improve their health and wellbeing. A core part of its strategy is the ongoing development to become a high-performing consumer healthcare company.

Recent filings

Filing Released Lang Actions
Group of companies' accounts made up to 2020-12-31
Regulatory Filings
2021-06-10 English
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number : 6201A' and contains the header 'NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)'. It details changes in voting rights ('An acquisition or disposal of voting rights') for a specific person ('John Dawson') concerning Alliance Pharma plc, referencing specific regulatory directives (Art 9 and Art 10 of Directive 2004/109/EC). This structure perfectly matches a notification of a change in major shareholding, which corresponds to the 'Major Shareholding Notification' definition (Code: MRQ). Although it is distributed via RNS, the content is highly specific to share ownership changes, making MRQ the most accurate classification over the general RNS fallback.
2021-06-02 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official notification released via RNS (RNS Number: 4871A) on June 1, 2021. The content explicitly states it is a notification in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1, providing the 'Total Voting Rights' as of a specific date (May 28, 2021). This type of filing, which reports the total number of shares and voting rights, is a standard regulatory disclosure. While it relates to share capital, it is not a formal share issue announcement (SHA) or a transaction in own shares (POS). It is a mandatory disclosure regarding the denominator for shareholder notifications. Since it is a specific regulatory announcement that doesn't fit the other precise categories (like AGM, 10-K, ER, DIV), it falls under the general regulatory filing category, RNS, which serves as the primary channel for such disclosures.
2021-06-01 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states, 'Result of AGM' and details that 'all the resolutions, as set out in the Notice of Meeting, were duly passed on a poll' at the 'Annual General Meeting'. It provides a detailed breakdown of votes FOR, AGAINST, and WITHHELD for each resolution, which is the core content of a Declaration of Voting Results (DVA). While it relates to the AGM, the primary focus is reporting the voting outcomes, not just general AGM materials (AGM-R) or proxy solicitation (PSI). The presence of the RNS Number and the closing statement confirms it is a regulatory announcement, but the specific content points directly to DVA.
2021-05-19 English
AGM Statement
AGM Information Classification · 99% confidence The document explicitly states it is an 'AGM Statement' from Alliance Pharma PLC, released on May 19, 2021, concerning the Annual General Meeting ('AGM') scheduled for that morning. It includes the Chairman's statement delivered at the AGM and details on how shareholders can access the hybrid meeting remotely. This content directly aligns with the definition of 'AGM Information'. Although it is distributed via RNS (Regulatory News Service), the primary subject matter is the AGM proceedings, making AGM-R the most specific classification.
2021-05-19 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short regulatory announcement identified by the 'RNS Number' and the header indicating it is provided by RNS, the news service of the London Stock Exchange, approved by the FCA. The content explicitly states the 'Total Voting Rights' as of a specific date (30 April 2021) and references the FCA's Disclosure and Transparency Rule 5.6.1. This type of notification regarding the total number of shares and voting rights is a standard regulatory disclosure. While it relates to share capital, it is not a formal share issue announcement (SHA) or a transaction in own shares (POS). It is a mandatory disclosure of voting rights denominator. Since it is a specific regulatory announcement that doesn't fit perfectly into the other defined categories (like ER, 10-K, DIV), and it is clearly an official regulatory release via RNS, the most appropriate classification is the general regulatory filing category, RNS, as it is a standard, short-form regulatory update.
2021-05-04 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.